Maximus

MMS · NYSE

$61.09−$0.24 (−0.39%)TodayMarket closed ·
Prev close $61.33

About MMS

MAXIMUS, Inc. engages in the operation of government health and human services programs, and the provision of technology solutions to government. The company is headquartered in Mclean, Virginia and currently employs 37,200 full-time employees. Its segments include U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment provides a variety of services, such as program operations, clinical services, employment services and advanced technology solutions and related professional services work for U.S. state and local government programs. The U.S. Federal Services segment delivers solutions that help various U.S. federal government agencies better execute on their mission, including program operations and management, clinical services, and advanced technology solutions. Outside the U.S. segment provides business process services and other solutions for international governments. These services include health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally enabled customer services, and advanced technologies for modernization.

Employees
37,200
Headquarters
McLean, Virginia
Listed
Jun 13, 1997
Sector
Industrials
Industry
Professional Services

MMS key statistics

Market cap
3.21B
Price-earnings ratio
9.07
Dividend yield
2.12%
Average volume
733.92K
Volume
637.54K
Open price
$62.15
High today
$63.11
Low today
$60.27
52 Week high
$100.00
52 Week low
$51.17

Maximus (MMS) at a glance

Maximus (MMS) last traded at $61.09, with a market cap of 3.21B, a price-to-earnings ratio of 9.07 and a dividend yield of 2.12%.

Today the stock has traded between $60.27 and $63.11. The current price is 1.4% above the day's low and 3.2% below its high.

Volume so far is 637.54K shares, in line with the average of 733.92K shares a day.

Over the past year Maximus has ranged from $51.17 to $100.00, and now sits 20% of the way up that range.

Maximus met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $2.22 per share against an estimate of $2.23.

MMS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 26.9% on average.

  1. Q3 FY24: reported $1.46 per share against an estimate of $1.35
  2. Q4 FY24: reported $1.19 per share against an estimate of $1.51
  3. Q1 FY25: reported $0.69 per share against an estimate of $1.07
  4. Q2 FY25: reported $2.01 per share against an estimate of $1.39
  5. Q3 FY25: reported $2.16 per share against an estimate of $1.43
  6. Q4 FY25: reported $1.62 per share against an estimate of $1.69
  7. Q1 FY26: reported $2.07 per share against an estimate of $1.98
  8. Q2 FY26: reported $2.22 per share against an estimate of $2.23

MMS news

  • Press releaseBusiness Wire

    Maximus to Acquire Agile Defense, Advancing Defense and National Security Growth Strategy

  • Press releaseBusiness Wire

    Maximus Schedules Fiscal 2026 Fourth Quarter and Year End Conference Call

  • Press releaseBusiness Wire

    Maximus Declares Quarterly Cash Dividend of $0.33 Per Share

  • Press releaseBusiness Wire

    Maximus Reports Fiscal Year 2026 Third Quarter Results

  • Press releaseBusiness Wire

    Maximus Schedules Fiscal 2026 Third Quarter Conference Call

  • Press releaseBusiness Wire

    Maximus Declares Quarterly Cash Dividend of $0.33 per Share

  • Press releaseBusiness Wire

    Maximus Reports Fiscal Year 2026 Second Quarter Results

  • Press releaseBusiness Wire

    Elizabeth Moellering Named General Counsel and Corporate Secretary of Maximus

Similar companies

Companies in the same industry as Maximus

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.